Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Tuberculosis and HIV news

Show

From To
Low implementation of Xpert MTB/RIF among adults with HIV/TB co-infection in 19 low- and middle-income countries

Three quarters of people with HIV/TB co-infection did not receive Xpert MTB/RIF testing for TB diagnosis between 2012 and 2014, according to a survey of cohorts in

Published
21 December 2015
By
Lesley Odendal
Death during MDR-TB treatment more likely in people with HIV and underweight or most drug-resistant patients

People living with HIV, those who are underweight and those with more extensive drug resistance are more likely to die during treatment for multi-drug resistant tuberculosis (MDR-TB),

Published
10 December 2015
By
Keith Alcorn
9-month MDR-TB regimen cures 82% in African study

A 9-month standardised treatment regimen for multi-drug resistant tuberculosis (MDR-TB) cured 82% of people recruited to an observational study in Francophone Africa, the 46th Union World Conference

Published
07 December 2015
By
Keith Alcorn
Scientists use breakthrough DNA technology to diagnose cases of TB faster

Whole Genome Sequencing is a faster, cheaper and more effective way of diagnosing tuberculosis says a new study published in the journal Lancet Respiratory Medicine.

Published
07 December 2015
From
University of Oxford press release
The Red Arrow – A Symbol to Unite Us Against TB

Today, we’re pleased to share the Red Arrow – a symbol for our solidarity towards a world without TB. The arrow represents our unwavering commitment to move forward with the mission until we reach the finish line to End TB.

Published
07 December 2015
From
Stop TB Partnership
First new TB drugs in half a century reach just 2% of people who need them

MSF calls for companies to make new drugs to treat drug-resistant TB available and affordable.

Published
04 December 2015
From
MSF
New cohort study shows promise of dramatically shorter treatment option for multidrug - resistant TB

New findings from clinical studies presented at the 46th Union World Conference on Lung Health show promise for a shorter, 9 -month treatment course for MDR-TB. The standard treatment length recommended by the World Health Organization requires 24 months of treatment.

Published
03 December 2015
From
46th Union World Conference on Lung Health
New survey shows outdated TB policies and practices risking further spread of drug-resistant TB

Urgent phase-out needed for outdated policies of mandatory hospitalisation, re-treatment regimens that contribute to drug resistance, and sub-optimal diagnosis.

Published
03 December 2015
From
MSF
TB Alliance and Partners Announce World’s First Availability of Appropriate, Child-friendly TB Medicines in Correct Doses

TB Alliance and its partners announced today the availability of child-friendly tuberculosis (TB) medicines in the correct doses. The improved treatments are the first to meet the dosage guidelines set by the World Health Organization (WHO) in 2010. They are dispersible and palatable, simple to administer and affordable. The availability of these products is a result of a project largely funded by UNITAID.

Published
03 December 2015
From
TB Alliance
Tuberculosis research funding crisis imperils elimination goal

Worldwide funding for tuberculosis (TB) research fell $1.3 billion short of global targets in 2014, according to a report released today by Treatment Action Group (TAG).

Published
01 December 2015
From
Treatment Action Group

Filter by country